Hydroxychloroquine PCD Pharma Franchise Company
Cafoli Lifecare offers 4 Hydroxychloroquine tablet formulations for PCD pharma franchise and third-party manufacturing. Every batch is produced in WHO-GMP certified facilities, giving distributors a dependable DMARD for the rheumatology segment.
What is Hydroxychloroquine?
Hydroxychloroquine is an antimalarial that also acts as a disease-modifying antirheumatic drug (DMARD). It modulates immune activity and reduces inflammation, which makes it valuable in autoimmune conditions in addition to its antimalarial role. See MedlinePlus for detailed drug information.
Therapeutic Applications
Hydroxychloroquine is used to treat rheumatoid arthritis, systemic and discoid lupus erythematosus and certain other autoimmune disorders, and in the prevention and treatment of malaria. It is prescribed chiefly by rheumatologists, physicians and dermatologists.
Why Hydroxychloroquine is a High-Potential Molecule for Distributors
Autoimmune diseases such as rheumatoid arthritis and lupus require long-term maintenance therapy, and hydroxychloroquine is a foundational DMARD in these protocols. Because patients stay on treatment for years with high adherence, a franchise partner gains steady repeat volume anchored to a defined base of rheumatology and internal-medicine prescribers.
Why Choose Cafoli Lifecare
Cafoli Lifecare supports partners with monopoly PCD rights, WHO-GMP manufacturing, DCGI-approved formulations, complete promotional inputs and a network of 1000+ franchise partners across India.
References
- MedlinePlus – Hydroxychloroquine
- WHO Model List of Essential Medicines
- PubChem – Hydroxychloroquine
Our formulations of Hydroxychloroquine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: